Human Papillomavirus in Menstrual Blood

Exploration of Optimal Experimental Settings to Detect Human Papillomavirus From Menstrual Blood in Women With High-grade Squamous Intraepithelial Lesion or High-risk Human Papillomavirus Infection

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01506128

Enrollment

Registered

2012-01-09

Start date

2012-01-31

Completion date

2013-01-31

Last updated

2013-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Human Papillomavirus

Keywords

HPV, Menstrual blood, HPV detection using menstrual blood

Brief summary

The investigators tried to know whether a virus causing cervical cancer could be detected in menstrual blood and to set up a experimental setting to detect the virus.

Interventions

OTHERCollecting a Pad used at the first menstrual period after enrollment

Collecting a Pad used at the first menstrual period after enrollment

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Inclusion criteria

* Premenopausal women with HSIL at Pap test or high-risk HPV

Exclusion criteria

* Suspicious cancer

Design outcomes

Primary

Measure	Time frame	Description
HPV detection rate in menstrual blood	First period after enrollment usually within 2 months after enrollment	The first menstrual period after enrollment is assumed to occur within 2 months. At that time, the participant used pads and send the used pads to investigators. The investigator do procedures to detect HPV in pads.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026